Inovio Pharmaceuticals, Inc. (INO)

$ 1.59
   
  • Change Today:
    $-0.10
  • 52 Week High: $2.87
  • 52 Week Low: $1.42
  • Currency: US Dollars
  • Shares Issued: 97.63m
  • Volume: 3,478,860
  • Market Cap: $155.23m
  • RiskGrade: 648

Inovio shares crash after FDA places partial hold on Covid-19 trial

By Alexander Bueso

Date: Monday 28 Sep 2020

LONDON (ShareCast) - (Sharecast News) - Inovio's phase 2/3 trial of its Covid-19 vaccine candidate was put on partial hold by the US Food and Drug Administration, sending the shares crashing.
The US biotechnology outfit said the partial hold was not due to any so-called "adverse event" during the trial.

Instead, the FDA had notified management that it had additional questions about the planned trial of INO-4800, including around the electroporation delivery technology with which it would be delivered, known as Cellectra 2000.

The biotech outfit said that it would respond to the regulator in October, after which the FDA would have 30 days to decide whether or not to allow the trial to proceed.

As of 1348 BST, shares of Inovio were falling 33.41% to $11.30.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

INO Market Data

Currency US Dollars
Share Price $ 1.59
Change Today $ -0.10
% Change -5.92 %
52 Week High $2.87
52 Week Low $1.42
Volume 3,478,860
Shares Issued 97.63m
Market Cap $155.23m
RiskGrade 648

Trades for 05-Jan-2026

Time Volume / Share Price
15:59 130 @ $1.60
15:59 100 @ $1.60
15:59 197 @ $1.59
15:59 100 @ $1.60
15:59 100 @ $1.60

Top of Page